Course Provider
Learning Objectives
1.Recognize the existing guidelines for chimeric antigen receptor (CAR) T-cell therapy.
2.Identify the common side effects and toxicities of CAR T-cell therapy.
3.Realize the limitations and challenges in the treatment of multiple myeloma and solid tumors.
4.Apply best practices in determining an individuals eligibility for CAR T therapy.